Florida Gov. Ron DeSantis announced Thursday that he is launching a rapid response unit to expand the use of monoclonal antibodies and relieve pressure at hospitals that continue to report a rise in COVID-19 patients. The drugs are delivered intravenously or by injection and made by Regeneron Pharmaceuticals. It concentrates doses of lab-made antibodies to fight COVID-19 and are geared toward people who are at high risk. DeSantis mentioned good candidates were elderly people and those with chronic kidney disease, diabetes, morbid obesity and sickle cell. • • • • • We strive to create a place for meaningful discussion on all our platforms. Due to staff time, the sheer number of comments and increasingly divisive discourse, we have disabled comments on all videos from the wire service and when threads diverge into attacks, spam or hateful talk.